ABSTRACT
INTRODUCTION
Despite many significant advances in the treatment of disease, many bacterial pathogens remain difficult to treat effectively as many strains have become either extremely (XDR) or totally drug resistant (TDR) to common clinically used antibiotics. 1 There are now limited therapeutic options for the diseases caused by these pathogens and the problem is expected to worsen in the future as bacteria exchange resistance genes and more strains become multi-drug resistant (MDR). The development of alternative antibacterial treatment modalities has become crucial and is considered by the World Health Organisation (WHO) to be one of the most serious challenges facing medical science. 2 For a number of reasons reviewed elsewhere, 1 it is unlikely that the previous methods of antibiotic discovery/development will be as successful in the future and new treatment modalities are urgently required. Plants produce a wide variety of secondary compounds, which provide them characteristic pigment, odour and flavour characteristics and may also give them antimicrobial properties. 3 Traditional plant derived medicines have been used in most parts of the world for a variety of therapeutic purposes, including fighting microbial disease. Indeed, the ability of plant extracts to block the growth of pathogenic bacteria has become the focus of much recent study. 4, 5 Much of the research into traditional medicinal plant use has focused on Asian, 6, 7 African [8] [9] [10] [11] [12] and South American 13, 14 plants. However, the therapeutic potential of the flora of Australia has also received recent attention. The first Australians had well-developed medicinal systems and understood the therapeutic properties of a wide variety of Australian plants and how to use them effectively. 15 Whilst studies have reported antibacterial activity for some Australian plant species, [16] [17] [18] [19] the antibacterial activity of many Australian native plants remains unexamined. Mischarytera lauteriana (F.M.Bailey) (Family Sapindaceae; synonyms Nephelium lauteriana (F.M.Bailey), Arytera lauteriana (F.M.Bailey); common name corduroy tamarind) is a species of rainforest tree that is endemic to the north eastern regions of Australia. It is a medium sized, sparsely branched understory tree which has wavy elongated leaves ( Figure 1a ). Small white-yellow flowers form as inflorescences (Figure 1b ). These flowers develop into fruit capsules containing bright orange fruit (Figure 1c ). M. lauteriana fruit were used as a nutritious food source by Australian Aborigines. Surprisingly, we were unable to find any studies examining either the therapeutic properties, nutritional value or the phytochemistry of this species. This study was undertaken to screen of M. lauteriana leaf extracts for the ability to inhibit the growth of a panel of gram-positive and gram-negative bacterial pathogens.
MATERIALS AND METHODS

Plant Collection and Extraction
Mischarytera lauteriana (F.M.Bailey) leaves were obtained from Philip Cameron, senior botanical officer, Mt Cootha Botanical Gardens, Brisbane, Australia. The leaf samples were dried in a Sunbeam food dehydrator and stored at -30 º C. Prior to use, the dried leaves were freshly ground to a coarse powder and 1g quantities were weighed into separate tubes. A volume of 50mL of AR grade methanol (Ajax Fine Chemicals, Australia) or sterile deionised water was added to individual 1g masses of the plant material and extracted for 24 hrs at 4ºC with gentle shaking. The extract was filtered through filter paper (Whatman No. 54) under vacuum, followed by lyophilisation. The resultant pellets were weighed to determine the extraction yield and subsequently dissolved in 10mL sterile deionised water (Containing 1% DMSO). The extracts were passed through 0.22µm filter (Sarstedt) and stored at 4 o C until use.
Qualitative Phytochemical Studies
Phytochemical analysis of the M. lauteriana leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by standard assays. 16, 17 Antibacterial Screening
Test Microorganisms
All media was purchased from Oxoid Ltd., Australia. The reference strains of E. coli (ATCC157293), Klebsiella pneumoniae (ATCC31488), Proteus mirabilis (ATCC21721) and Streptococcus pyogenes (ATCC19615) were purchased from American Tissue Culture Collection (ATCC), USA. Clinical isolate microbial strains of Bacillus cereus and Staphylococcus aureus were obtained from Ms Michelle Mendell and Ms Jane Gifkins, Griffith University. All stock cultures were subcultured and maintained in nutrient broth at 4 o C.
Evaluation of Antimicrobial Activity
Antimicrobial activity of the M. lauteriana leaf extracts was determined using a modified disc diffusion assay. [20] [21] [22] [23] Briefly, 100µL of the each bacterial suspension in log phase was spread onto individual nutrient agar plates and the extracts were tested for antibacterial activity using 6mm sterilised filter paper discs. The discs were each infused with 10µL of the individual plant extract, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2 h before incubation at 37°C for 24 h. The diameters of the zones of inhibition (ZOIs) were measured to the closest whole millimetre. Each assay was performed three times in triplicate (n=9). Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10µg) and chloramphenicol (10µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10µL of distilled water were used as a negative control.
Minimum Inhibitory Concentration (MIC) Determination
The minimum inhibitory concentration (MIC) of each extract against susceptible bacteria was determined as previously described. 24, 25 Briefly, the M. lauteriana leaf extracts were diluted in deionised water (1% DMSO) and tested across a range of concentrations. Discs were individually infused with 10µL of each extract, allowed to dry and placed onto the inoculated plates. The assay was completed as outlined above and graphs of the ZOI versus ln concentration were plotted for each extract. Linear regression was used to determine the MIC values of each extract.
Bacterial Growth Time Course Assay
Bacterial growth time course studies were performed as previously described. 26 Briefly, 3mL of the gram-positive bacterial species in nutrient broth were individually added to 27mL nutrient broth containing 3mL of 10mg/mL of the extract to give a final extract concentration of 1000µg/ mL in the assay. The tubes were incubated at 37 o C with gentle shaking. The optical density was measured hourly at 550nm for a 6h incubation period. Control tubes were incubated under the same conditions but without the extract. All assays were performed three times in triplicate (n=9).
Toxicity Screening
Artemia franciscana Nauplii Toxicity Screening Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [27] [28] [29] Briefly, A. franciscana nauplii were incubated in the presence of the extracts, reference toxin (1mg/mL potassium dichromate) or artificial seawater (Negative control) at 25±1 º C under artificial light. All treatments were performed three times in triplicate (n=9). The number of dead were counted in each well at 24h and 48h. At the completion of the 48h exposure period, the remaining live nauplii were sacrificed and the total number of nauplii in each well were counted and used to calculate the % mortality per well. LC 50 values were calculated for each treatment using probit analysis.
Statistical Analysis
Data are expressed as the mean ± SEM of three independent experiments with internal triplicates (n=9). One-way ANOVA was used to calculate statistical significance between control and treated groups, with a P value <0.01 considered to be statistically significant.
RESULTS
Liquid Extraction Yields and Qualitative Phytochemical Screening
Extraction of 1g of dried and powdered M. lauteriana leaves with methanol and water yielded 256 and 184mg of extracted material respectively ( Table 1) . The extracts were resuspended in 10mL of deionised water (Containing 1% DMSO), resulting in an extract concentration shown in Table 1 . Qualitative phytochemical studies showed that both extracts had similar phytochemical profiles. Both contained high levels of phenolic compounds as well as moderate levels of flavonoids, triterpenoids and saponins. Lower levels of tannins were also detected. Cardiac glycosides, phytosterols, alkaloids and anthraquinones were completely absent or below the detection thresholds for these assays.
Antimicrobial Activity
To determine the growth inhibitory activity of the M. lauteriana leaf extracts, aliquots (10µL) of each extract were screened in the disc diffusion assay. The M. lauteriana leaf extracts were effective at inhibiting the growth of 2 of the 3 gram-negative bacterial species tested ( Figure  2 ). For both of these bacteria, the methanolic extract was a substantially more potent inhibitor of bacterial growth than the aqueous extract was. 
coli).
The gram-positive bacterial species appeared more susceptible to the extracts than the gram-negative species. Indeed, the growth of all gram-positive bacteria was inhibited by the M. lauteriana leaf extracts ( Figure 3 ). As noted for the gram-negative bacteria, the methanolic extract was a substantially better inhibitor of gram-positive bacterial growth. B. cereus was most susceptible to the inhibitory effects of the extracts, with ZOIs of nearly 11mm measured (Figure 3) . Indeed, the methanolic extract produced ZOIs that were only slightly smaller than the chloramphenicol control. This is noteworthy as the controls were tested at relatively high doses (10μg/disc). Furthermore, the control antibiotics are pure compounds, whereas the extracts are crude mixtures and the active compound(s) would be expected to be a minor % of the overall extracts mass. Therefore, these extracts may be particularly promising as targets for antibiotic drug discovery. The methanolic M. lauteriana leaf extract was also an effective inhibitors of S. pyogenes growth ( Figure  3 ), albeit with a smaller ZOI (~8mm) noted. The ZOI measured against this bacterium was comparable to that of the chloramphenicol control, demonstrating its potential for the development of novel antibacterial chemotherapeutics. As S. pyogenes can cause a wide variety of diseases including pharyngitis, impetigo and rheumatic fever depending on the tissue that it infects, these extracts may be particularly useful as targets for antibiotic discovery. Only the methanolic M. lauteriana leaf extract inhibited the growth of S. aureus, whilst the aqueous extract was completely ineffective. Smaller ZOIs (7.3mm) were recorded against this bacterium, indicating only low to moderate activity. The antimicrobial efficacy was further quantified by determining the MIC value. The methanolic and aqueous extracts were particularly good inhibitors of K. pneumoniae (MICs of 728 and 953μg/mL for the methanolic and aqueous extracts respectively) and B. cereus growth (MICs of 515 and 860μg/mL for the methanolic and aqueous extracts respectively). Both extracts were also moderate inhibitors of P. mirabilis growth (MIC values of 1126 and 2030µg/mL respectively), whilst the methanolic extract was also a moderate inhibitor of S. aureus growth (MIC = 1388 µg/mL). E. coli was completely resistant to the methanolic and aqueous M. lauteriana leaf extracts at all concentrations tested.
Bacterial Growth Time Course Assay
The antibacterial activity of the M. lauteriana leaf methanolic and aqueous extracts was further investigated against K. pneumonia and B. cereus by bacterial growth time course assays in the presence and absence of the extracts (Figure 4) . The starting concentration of the extract used in these assays was 1000µg/mL. The M. lauteriana leaf methanolic and aqueous leaf extracts both significantly inhibited K. pneumoniae within 1h of exposure, indicating a rapid antimicrobial action (Figure 4a ). The absorbance of the K. pneumonia culture remained substantially lower than the untreated control for the first 4 hrs of exposure. After that time, the absorbance increased to approximately the same level as the control, indicating that the methanolic and aqueous extracts are bacteriostatic rather than bacteriocidal at the concentrations tested. A different trend was noted for the M. lauteriana leaf methanolic extracts against when tested against B. cereus growth (Figure 4b) . Th e absorbance of the B. cereus culture (and thus the bacterial growth) remained substantially lower than the untreated control for the entire 6 h incubation period, indicating that the methanolic extract may be bacteriocidal at the concentrations tested (Figure 4b ). The aqueous extract was also rapid in its inhibition of B. cereus growth, with a significant decrease in bac- terial growth also noted within the first hour of incubation. However, in contrast to the inhibition of B. cereus growth by the methanolic extract, B. cereus growth had returned to similar levels to that of the untreated control by the end of the 6h incubation period (as judged by turbidity). This may indicate that the aqueous M. lauteriana leaf extracts had bacteriostatic effects at the tested concentration, rather than bactericidal effects.
Quantification of Toxicity
The toxicity of the M. lauteriana leaf extracts was initially tested at 2mg/ mL in the A. franciscana nauplii bioassay ( Figure 5 ). The mortality in the presence of both extracts was not significantly different to that of the untreated control at 24h and thus they were deemed to be non-toxic. Extracts with 24h LC 50 values >1000µg/mL have previously been defined as non-toxic. 28, 29 In contrast, the potassium dichromate positive control induced substantial mortality within 4h (Results not shown), with 100% mortality induction seen by 24h. The mortality induction remained low for the M. lauteriana leaf extracts at 48h. Indeed, the % mortality induction was substantially <50% for all extracts at all times tested and therefore it was not possible to determine LC 50 values for any of the M. lauteriana leaf extracts (Table 2) .
DISCUSSION
Despite the initial potency of many antibiotic chemotherapies, recent increases in bacterial resistance to many antibiotics has made the development of new antibiotic therapies a high priority. 1 A parallel decrease in the introduction of new antibiotic therapies in recent years has further compounded this problem. As a result, interest in re-evaluating medicinal plants for new antibiotic chemotherapies has escalated substantially. 30 Interestingly, we were unable to find records of the medicinal usage of M. lauteriana by Australian Aborigines. Furthermore, no scientific evaluations have yet evaluated any therapeutic properties of this species. To the best of our knowledge, this is the first study to report bacterial growth inhibitory activity for this species. The ability of the M. lauteriana leaf extracts to inhibit the growth of both gram-positive and gram-negative bacteria is in agreement with previous reports of the antibacterial activity of other Australian plant species. 31, 32 However, a slightly greater susceptibility of the gram-positive bacteria was noted compared to the gram-negative species. The greater susceptibility of gram-positive bacteria to the M. lauteriana leaf extracts noted in this study is in agreement with previously reported results for South American, 13, 33 African 34, 35 and Australian 36 plant extracts. Results within our laboratory have also confirmed the greater susceptibility of gram-positive bacteria towards other Australian plant extracts. 37, 38 The gram-negative bacterial cell wall outer membrane is thought to act as a barrier to many substances including antibiotics. 39 The uptake of the M. lauteriana leaf extract antibiotic compounds by gram-negative bacteria is presumably affected by the cell wall outer membrane. In contrast, other studies have demonstrated that gram-negative bacteria are often more susceptible to plant extracts from different Australian plant species. [40] [41] [42] Whilst an investigation of the phytochemistry of the M. lauteriana leaf extracts was beyond the scope of our study, moderate to high levels of polyphenolics, flavonoids, triterpenoids and saponins were noted in the extracts in the qualitative phytochemical screening study. Lower levels of tannins were also detected. Flavonoids have well established bacterial growth inhibitory activities. 43 The flavonoids kaempferol and myricetin have been reported to be potent growth inhibitors of a panel of bacterial pathogens. 44 Similarly, quercetin, rutin and their corresponding glycosides inhibit the growth of Pseudomonas maltophilia and Enterobacter cloacae. 45 The antimicrobial activity of terpenoids has also been extensively documented. Monoterpenoids including α-pinene, β-pinene, sabinene, mycrene, terpinene, limonene, piperitone and β-phellandrene inhibit the growth of a panel of bacteria, including several antibiotic resistant strains of Enterobacteriaceae. 43 The antibacterial activities for several sesquiterpenoids including α-cubebene, copaene and caryophyllene have been reported. 43 Similarly, many tannin compounds have bacterial growth inhibitory activity. Gallotannins inhibit the growth of a broad spectrum of bacterial species 46 through a variety of mechanisms including binding cell surface molecules including lipotoichoic acid and proline-rich cell surface proteins, 47, 48 and by inhibiting glucosyltransferase enzymes.
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Figure 5: The lethality of the M. lauteriana leaf extracts (2000µg/mL), potassium dichromate control (1000µg/mL) and seawater (negative control). All bioassays were performed three times in triplicate (n=9) and are expressed as mean ± SEM. * indicates results that are significantly different to the untreated (seawater) control at the equivalent exposure time (P<0.01). " Elligitannins are also highly potent inhibitors of bacterial growth, with MIC values as low as 62.5 µg/mL. 46, 48 Ellagitannins have also been reported to function via several antibiotic mechanisms including interaction with cytoplasmic oxidoreductases and by disrupting bacterial cell walls. 46, 48 Thus, it is likely that multiple compounds within the M. lauteriana leaf extracts are contributing to the antibacterial activity reported here. The findings reported here also indicate that the extracts examined were non-toxic (LC 50 >1000 µg/mL) in the Artemia nauplii bioassay. Whilst toxicity was assessed in this study with the test organism A. franciscana, toxicity towards A. franciscana has previously been shown to correlate well with toxicity towards human cells for many toxins. 28, 29 However, further studies are required to determine whether this is also true for the M. lauteriana leaf extracts examined in these studies. The results of this study indicate that the M. lauteriana leaf extracts may be good candidates for antimicrobial drug discovery and further examination is warranted. Whilst the extracts examined in this report have potential as bacterial growth inhibitors, caution is needed before these compounds can be applied to medicinal purposes. Purification and identification of the bioactive components is needed to examine the mechanisms of action of these agents.
CONCLUSION
The growth inhibitory activity of the M. lauteriana leaf extracts against gram-positive and gram-negative bacteria and their lack of toxicity indicate their potential for the development of novel chemotherapies to treat a variety of diseases caused by bacterial pathogens. Further studies aimed at the purification of the bioactive components are needed to examine the mechanisms of action of these agents.
